Advanced search
Publication Cover
Future Medicinal Chemistry Volume 2, 2010 - Issue 7
Submit an article Journal homepage
43
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Therapeutic Implications of New Insights into the Critical Role of Vp16 in Initiating the Earliest Stages of Hsv Reactivation from Latency

Richard L Thompson1 Department of Molecular Genetics, Microbiology, and Biochemistry, University of Cincinnati School of Medicine, Cincinnati, OH45267–0524, USAView further author information
&
Nancy M Sawtell2 Department of Pediatrics, Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio45229–3039, USACorrespondence[email protected]
View further author information
Pages 1099-1105 | Published online: 12 Jul 2010

Bibliography

  • Knipe DM . Field’s Virology (5th). Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2 (2007).
  • Fuchs J , CelumC, WangJet al. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J. Infect. Dis. 201(8), 1164–1168 (2010).
  • Zhu J , HladikF, WoodwardAet al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15(8), 886–892 (2009).
  • Itzhaki RF , WozniakMA. Herpes simplex virus type 1 in alzheimer’s disease: the enemy within.J. Alzheimers Dis.13(4), 393–405 (2008).
  • Goodpasture EW . Herpetic infections with special reference to involvement of the nervous system.Medicine8, 223–235 (1929).
  • Wysocka J , HerrW. The herpes simplex virus vp16-induced complex: the makings of a regulatory switch.Trends Biochem. Sci.28(6), 294–304 (2003).
  • Weir JP . Regulation of herpes simplex virus gene expression.Gene271(2), 117–130 (2001).
  • Stevens JG , WagnerEK, Devi-RaoGB, CookML, FeldmanLT. RNA complementary to a herpes virus α gene mRNA is prominent in latently infected neurons.Science235(4792), 1056–1059 (1987).
  • Sawtell NM . Comprehensive quantification of herpes simplex virus latency at the single-cell level.J. Virol.71(7), 5423–5431 (1997).
  • Sawtell NM . The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol.72(8), 6888–6892 (1998).
  • Sawtell NM . Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation. J. Virol.77(7), 4127–4138 (2003).
  • Sawtell NM , ThompsonRL. Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences. J. Virol.78(14), 7784–7794 (2004).
  • Sawtell NM , ThompsonRL, HaasRL. Herpes simplex virus DNA synthesis is not a decisive regulatory event in the initiation of lytic viral protein expression in neurons in vivo during primary infection or reactivation from latency. J. Virol.80(1), 38–50 (2006).
  • Whitley RJ . Herpes simplex virus infection.Semin. Pediatr. Infect. Dis.13(1), 6–11 (2002).
  • Thompson RL , SawtellNM. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival.J. Virol.75(14), 6660–6675 (2001).
  • Sawtell NM . Thompson RL. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol.66(4), 2150–2156 (1992).
  • Preston CM , FrameMC, CampbellME. A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence.Cell52(3), 425–434 (1988).
  • Kristie TM , RoizmanB. Host cell proteins bind to the cis-acting site required for virion-mediated induction of herpes simplex virus 1 α genes. Proc Natl Acad Sci USA84(1), 71–75 (1987).
  • Stern S , TanakaM, HerrW. The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16.Nature341(6243), 624–630 (1989).
  • Triezenberg SJ , LamarcoKL, McknightSL. Evidence of DNA: protein interactions that mediate HSV-1 immediate early gene activation by VP16.Genes Dev.2(6), 730–742 (1988).
  • Sears AE , HukkanenV, LabowMA, LevineAJ, RoizmanB. Expression of the herpes simplex virus 1 α transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice.J. Virol.65(6), 2929–2935 (1991).
  • Ace CI , MckeeTA, RyanJM, CameronJM, PrestonCM. Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression.J. Virol.63(5), 2260–2269 (1989).
  • Steiner I , SpivackJG, DeshmaneSL, AceCI, PrestonCM, FraserNW. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J. Virol.64(4), 1630–1638 (1990).
  • Valyi-Nagy T , DeshmaneSL, RaengsakulrachBet al. Herpes simplex virus type 1 mutant strain IN1814 establishes a unique, slowly progressing infection in SCID mice. J. Virol. 66(12), 7336–7345 (1992).
  • Ecob-Prince MS , RixonFJ, PrestonCM, HassanK, KennedyPG. Reactivation in vivo and in vitro of herpes simplex virus from mouse dorsal root ganglia which contain different levels of latency-associated transcripts. J. Gen. Virol.74(Pt 6), 995–1002 (1993).
  • Katz JP , BodinET, CoenDM. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants.J. Virol.64(9), 4288–4295 (1990).
  • Sawtell NM , ThompsonRL. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.J. Virol.66(4), 2157–2169 (1992).
  • Cai W , AstorTL, LiptakLM, ChoC, CoenDM, SchafferPA. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency.J. Virol.67(12), 7501–7512 (1993).
  • Halford WP , SchafferPA. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.J. Virol.75(7), 3240–3249 (2001).
  • Knickelbein JE , KhannaKM, YeeMB, BatyCJ, KinchingtonPR, HendricksRL. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency.Science322(5899), 268–271 (2008).
  • Kosz-Vnenchak M , JacobsonJ, CoenDM, KnipeDM. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons.J. Virol.67(9), 5383–5393 (1993).
  • Thompson RL , RogersSK, ZerhusenMA. Herpes simplex virus neurovirulence and productive infection of neural cells is associated with a function which maps between 0.82 and 0.832 map units on the HSV genome.Virology172(2), 435–450 (1989).
  • Thompson RL , SawtellNM. Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo. J. Virol.80(22), 10919–10930 (2006).
  • Thompson RL , ShiehMT, SawtellNM. Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo. J. Virol.77(22), 12319–12330 (2003).
  • Thompson RL , PrestonCM, SawtellNM. De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoS Pathog.5(3), e1000352 (2009).
  • Hufner K , DerfussT, HerbergerSet al. Latency of α-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J. Neuropathol. Exp. Neurol. 65(10), 1022–1030 (2006).
  • Tyler KL . Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including mollaret‘s.Herpes11(Suppl. 2), 57A–64A (2004).
  • Hukkanen V , BrobergE, SalmiA, EralinnaJP. Cytokines in experimental herpes simplex virus infection.Int. Rev. Immunol.21(4–5), 355–371 (2002).
  • Fleer A , KredietTG. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn.Neonatology92(3), 145–157 (2007).
  • Rouse BT , KaisthaSD. A tale of 2 α-herpesviruses: lessons for vaccinologists.Clin. Infect. Dis.42(6), 810–817 (2006).
  • Yarlagadda SG , PerazellaMA. Drug-induced crystal nephropathy: an update.Expert Opin. Drug Saf.7(2), 147–158 (2008).
  • Liang Y , VogelJL, NarayananA, PengH, KristieTM. Inhibition of the histone demethylase LSD1 blocks α -herpesvirus lytic replication and reactivation from latency.Nat. Med.15(11), 1312–1317 (2009).
  • Haigh A , GreavesR, O‘HareP. Interference with the assembly of a virus-host transcription complex by peptide competition.Nature344(6263), 257–259 (1990).
  • Lai JS , HerrW. Interdigitated residues within a small region of VP16 interact with Oct-1, HCF and DNA.Mol. Cell Biol.17(7), 3937–3946 (1997).
  • Kuo YC , KuoYH, LinYL, TsaiWJ. Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression. Antiviral Res.70(3), 112–120 (2006).
  • Kuo YC , LinLC, TsaiWJ, ChouCJ, KungSH, HoYH. Samarangenin b from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis. Antimicrob. Agents Chemother.46(9), 2854–2864 (2002).
  • Lin LC , KuoYC, ChouCJ. Anti-herpes simplex virus type-1 flavonoids and a new flavanone from the root of limonium sinense.Planta Med.66(4), 333–336 (2000).
  • Deshmane SL , FraserNW. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure.J. Virol.63(2), 943–947 (1989).
  • Knipe DM , CliffeA. Chromatin control of herpes simplex virus lytic and latent infection.Nat. Rev. Microbiol.6(3), 211–221 (2008).
  • Pankiewicz R , KarlenY, ImhofMO, MermodN. Reversal of the silencing of tetracycline-controlled genes requires the coordinate action of distinctly acting transcription factors.J. Gene Med.7(1), 117–132 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.